Conversely, significantly lower serum adiponectin levels were observed in the psoriasis patients compared to the control group; the median concentration was significantly lower in the psoriasis patients (6.1 μg/mL, range: 2.1–13 μg/mL) compared to the controls (9.1 μg/mL, range: 3.9–17 μg/mL; p < 0.001, effect size = 0.13). Here, ADIPOQ is linked to psoriasis.